Graham Juan, CFO of Perspective Therapeutics Inc. ($CATX), made one open market purchase of common shares in the last 365 days, totaling about $75,000. His most recent buy occurred on March 28, 2025. This places him 2,645th among 4,983 individual insiders by purchase value, compared to an average of $1.5 million per insider and 3.3 transactions. Juan reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 28, 2025 | Perspective Therapeutics, Inc. | $CATX | Graham Juan | Chief Financial Officer | P | Common Stock | 33333 | $2.25 | 35,354.0000 | 74,051,841 | 1649.33% | 0.05% |
| Jan. 6, 2025 | Perspective Therapeutics, Inc. | $CATX | Graham Juan | Chief Financial Officer | A | Stock option (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 7, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1066 | $0.34 | 164,863.0000 | 98,770,000 | 0.64% | 0.00% |
| Dec. 6, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1446 | $0.34 | 165,929.0000 | 98,770,000 | 0.86% | 0.00% |
| Sept. 6, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 16050 | $0.39 | 168,440.0000 | 98,770,000 | 8.70% | 0.02% |
| Sept. 7, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1065 | $0.39 | 167,375.0000 | 98,770,000 | 0.63% | 0.00% |
| June 6, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 17797 | $1.19 | 185,672.0000 | 98,770,000 | 8.75% | 0.02% |
| June 7, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1182 | $1.10 | 184,490.0000 | 98,770,000 | 0.64% | 0.00% |
| March 6, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 422 | $1.87 | 204,650.0000 | 98,770,000 | 0.21% | 0.00% |
| March 7, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 1181 | $1.79 | 203,469.0000 | 98,770,000 | 0.58% | 0.00% |
| March 6, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | A | Common Stock | 781 | $0.00 | 205,072.0000 | 98,770,000 | 0.38% | 0.00% |
| March 6, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | F | Common Stock | 20327 | $1.87 | 204,291.0000 | 98,770,000 | 9.05% | 0.02% |
| Feb. 21, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | A | Common Stock | 52000 | $0.00 | 224,618.0000 | 98,770,000 | 30.12% | 0.05% |
| Feb. 21, 2024 | KYNTRA BIO, INC. | $KYNB | Graham Juan | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 260000 | $0.00 | 260,000.0000 | 98,770,000 | 9999.99% | 0.26% |
| Dec. 7, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | F | Common Stock | 1085 | $0.62 | 172,618.0000 | 0 | 0.62% | 0.00% |
| Dec. 6, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | F | Common Stock | 15573 | $0.58 | 173,703.0000 | 0 | 8.23% | 0.00% |
| Sept. 6, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | F | Common Stock | 711 | $0.96 | 190,372.0000 | 0 | 0.37% | 0.00% |
| Sept. 7, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | F | Common Stock | 1096 | $0.99 | 189,276.0000 | 0 | 0.58% | 0.00% |
| Aug. 30, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | A | Common Stock | 120000 | $0.00 | 191,083.0000 | 0 | 168.82% | 0.00% |
| Aug. 30, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | A | Stock Option (Right to Buy) | 220000 | $0.00 | 220,000.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | S | Common Stock | 1050 | $16.95 | 71,818.0000 | 0 | 1.44% | 0.00% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | S | Common Stock | 735 | $17.04 | 71,083.0000 | 0 | 1.02% | 0.00% |
| March 8, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | S | Common Stock | 2749 | $21.16 | 70,213.0000 | 0 | 3.77% | 0.00% |
| March 8, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | A | Common Stock | 2899 | $0.00 | 73,112.0000 | 0 | 4.13% | 0.00% |
| March 8, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | A | Common Stock | 4668 | $0.00 | 77,780.0000 | 0 | 6.38% | 0.00% |
| March 10, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | S | Common Stock | 1112 | $20.20 | 76,668.0000 | 0 | 1.43% | 0.00% |
| March 10, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | S | Common Stock | 1456 | $20.20 | 75,212.0000 | 0 | 1.90% | 0.00% |
| March 10, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | S | Common Stock | 2344 | $20.20 | 72,868.0000 | 0 | 3.12% | 0.00% |
| Feb. 21, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | A | Common Stock | 25000 | $0.00 | 72,962.0000 | 0 | 52.12% | 0.00% |
| Feb. 21, 2023 | KYNTRA BIO, INC. | $KYNB | Graham Juan | Chief Financial Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |